Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response.
about
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Clinical Practice Updates in the Management Of Immune Thrombocytopenia.Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.Spleen tyrosine kinase inhibition: a new promising approach to chronic and refractory immune thrombocytopenia.
P2860
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response.
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Rituximab in immune thrombocyt ...... dictors of long-term response.
@ast
Rituximab in immune thrombocyt ...... dictors of long-term response.
@en
type
label
Rituximab in immune thrombocyt ...... dictors of long-term response.
@ast
Rituximab in immune thrombocyt ...... dictors of long-term response.
@en
prefLabel
Rituximab in immune thrombocyt ...... dictors of long-term response.
@ast
Rituximab in immune thrombocyt ...... dictors of long-term response.
@en
P2093
P2860
P50
P356
P1476
Rituximab in immune thrombocyt ...... edictors of long-term response
@en
P2093
Cristina Santoro
Elisa Lucchini
Maria Gabriella Mazzucconi
Miriam Isola
Miriam Marangon
Monica Carpenedo
Nicola Vianelli
Renato Fanin
Stefano Volpetti
Wilma Barcellini
P2860
P304
P356
10.1111/EJH.12839
P577
2017-01-20T00:00:00Z